文献速递外周动脉疾病

女性性别对症状性外周动脉闭塞性疾病腔内血运重建术后长期结局的影响:健康保险理赔分析

A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease.
PubMed 文献 · J Vasc Surg · 2021-02-27

基于德国BARMER保险理赔数据,纳入2010至2018年因症状性外周动脉闭塞性疾病接受经皮腔内血运重建的患者,按间歇性跛行、缺血性静息痛和伤口愈合障碍分层,并用倾向性评分匹配调整混杂。匹配队列35232例中,女性在全分层中均显示较低死亡、截肢或死亡、心血管事件或死亡风险,间歇性跛行患者中关联最强。

要点

  • 女性症状性PAOD患者经皮腔内血运重建后5年死亡、截肢或死亡、心血管事件或死亡风险均低于男性。
  • 女性性别与长期结局改善的关联在间歇性跛行患者中最为显著。
  • 研究采用倾向性评分匹配调整年龄、治疗血管区域、合并症和药物治疗等混杂因素。

核心结论

  • 在症状性PAOD经皮腔内血运重建术后5年随访中,女性心血管事件无生存、截肢无生存和总生存均优于男性。

研究设计与样本

  • 共识别50051例患者(女性47.2%),构建35232例的倾向性评分匹配队列,按间歇性跛行、缺血性静息痛和伤口愈合障碍分层。

主要发现

  • 在所有分层中,女性死亡率较低(HR 0.69-0.90)。
  • 女性截肢或死亡风险较低(HR 0.70-0.89)。
  • 女性心血管事件或死亡风险较低(HR 0.78-0.91)。
  • 女性性别与长期结局改善的关联在间歇性跛行患者中最为显著。

临床怎么用

  • 对于症状性PAOD接受经皮腔内血运重建的患者,女性性别可视为长期结局较好的相关因素。
  • 临床随访和风险分层时可考虑性别差异,但需结合分层疾病严重程度综合评估。

局限性

  • 研究基于健康保险理赔数据,可能存在编码偏倚和未测量混杂。
  • 结论仅适用于经皮腔内血运重建患者,不涉及开放手术治疗。
  • 原文未报告具体P值、置信区间及匹配前后样本量细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Several reports have addressed sex disparities in peripheral arterial occlusive disease (PAOD) treatment with inconclusive or even conflicting results. However, most previous studies have neither been sufficiently stratified nor used matching or weighting methods to address severe confounding. In the present study, we aimed to determine the disparities between sexes after percutaneous endovascular revascularization (ER) for symptomatic PAOD. METHODS: Health insurance claims data from the second-largest insurance fund in Germany, BARMER, were used. A large cohort of patients who had undergone index percutaneous ER of symptomatic PAOD from January 1, 2010 to December 31, 2018 were included in the present study. The study cohort was stratified by the presence of intermittent claudication, ischemic rest pain, and wound healing disorders. Propensity score matching was used to adjust for confounding through differences in age, treated vessel region, comorbidities, and pharmacologic treatment. Sex-related differences regarding cardiovascular event-free survival, amputation-free survival, and overall survival within 5 years of surgery were determined using Kaplan-Meier time-to-event curves, log-rank test, and Cox regression analysis. RESULTS: In the present study, 50,051 patients (47.2% women) were identified and used to compose a matched cohort of 35,232 patients. Among all strata, female patients exhibited lower mortality (hazard ratio [HR], 0.69-0.90), fewer amputations or death (HR, 0.70-0.89), and fewer cardiovascular events or death (HR, 0.78-0.91). The association between female sex and improved long-term outcomes was most pronounced for the patients with intermittent claudication. CONCLUSIONS: In the present propensity score-matched analysis of health insurance claims, we observed superior cardiovascular event-free survival, amputation-free survival, and overall survival during 5 years of follow-up after percutaneous ER in women with symptomatic PAOD. Future studies should address sex disparities in the open surgical treatment of PAOD to illuminate whether the conflicting data from previous reports might have resulted from insufficient stratification of the studies.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Heidemann F, Kuchenbecker J, Peters F, et al. A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease. J Vasc Surg. 2021. PMID: 33647437. doi:10.1016/j.jvs.2021.01.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。